Porter S, Flint S, Scully C, Keith O
Centre for the Study of Oral Disease, Bristol Dental Hospital and School.
Ann Dent. 1992 Winter;51(2):14-6.
A group of thirty-four patients with recurrent aphthous stomatitis (RAS) and single hematinic deficiencies were given replacement therapy after any reason for the deficiency had been sought and excluded. The response of the RAS was assessed in an open trial. The aphthae in 70% of patients subjectively improved with hematinic replacement therapy, a benefit exceeding the defined placebo response in recurrent aphthous stomatitis.
一组34例复发性阿弗他口炎（RAS）且伴有单一造血物质缺乏的患者，在寻找并排除了导致缺乏的任何原因后，接受了替代疗法。在一项开放性试验中评估了RAS的反应。70%的患者在接受造血物质替代疗法后，口腔溃疡主观上有所改善，这一益处超过了复发性阿弗他口炎中定义的安慰剂反应。
